معرفی
Ola Åberg is a Researcher at Uppsala University working within the Department of Medicinal Chemistry and the Preclinical PET-MRI Platform. His primary role involves radiopharmaceutical organic chemistry research with a focus on developing novel imaging agents for cancer and neurological applications. In addition to his research activities, Åberg serves as the IT e-coordinator for Research administration and Handling of research data at the university, and is an active member of the Research data support group at Uppsala.
Åberg completed his PhD at Uppsala University between 2005 and 2009 in the Department of Biochemistry and Organic Chemistry. Following his doctoral studies, he worked as a Research Associate at Imperial College London from 2010 to 2012 before returning to Uppsala University in 2012, where he has remained as a Researcher and e-coordinator.
Dr. Åberg's research spans several key areas in radiopharmaceutical sciences. His primary focus is on radiochemistry with isotopes including 11C, 18F, 68Ga, and 125I, with particular expertise in transition metal catalysis and bioorthogonal chemistry approaches. His work has significant applications in cancer imaging and neuroimaging, where he develops novel PET tracers for molecular imaging applications. More recently, he has expanded his research interests to include educational challenges in nanotechnology, publishing two significant papers on the topic in 2023.
Analysis of Åberg's publication record reveals a consistent focus on developing novel radiolabeling techniques and molecular imaging probes. His early work centered on carbon-11 labeling methodologies and applications to receptors like EGFR, VEGFr, and angiotensin receptors. Over time, his research evolved to include fluorine-18 labeling, peptide-based imaging agents, and more recently, applications in nanotechnology education. A recurring theme throughout his career has been the development of innovative chemical methodologies for producing PET tracers with high specific activity and targeting precision.
Within his administrative role as IT e-coordinator, Åberg manages several critical research data systems including Biovia Notebook, REDCap, iLab, Doktoranddatabasen, Disputationskalendern, and Allvis. This dual role as both researcher and research administration specialist gives him a unique perspective on the intersection of scientific discovery and research data management.
Åberg's laboratory work primarily takes place within the Preclinical PET Platform at Uppsala University, where he collaborates with multidisciplinary teams of chemists, biologists, and medical researchers. His work often involves close collaboration with clinical researchers to translate novel imaging agents from bench to bedside.
